TipRanks
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Hong Kong Market
2877
China Shineway Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:2877 full AI Analyst Report?

China Shineway Pharmaceutical Group Limited (2877) Ratios

0 Followers

China Shineway Pharmaceutical Group Limited Ratios

HK:2877's free cash flow for Q2 2026 was ¥0.70. For the 2026 fiscal year, HK:2877's free cash flow was decreased by ¥ and operating cash flow was ¥0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.32 3.71 3.51 3.35 4.07
Quick Ratio
 4.05 3.43 3.18 2.98 3.68
Cash Ratio
 3.61 2.86 2.51 2.42 3.02
Solvency Ratio
 0.42 0.38 0.39 0.45 0.49
Operating Cash Flow Ratio
 0.51 0.47 0.39 0.38 0.67
Short-Term Operating Cash Flow Coverage
 3.42 3.61 2.92 3.11 0.00
Net Current Asset Value
¥ 6.76B¥ 6.59B¥ 6.02B¥ 5.62B¥ 4.93B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.03 <0.01
Debt-to-Equity Ratio
 0.04 0.04 0.05 0.04 <0.01
Debt-to-Capital Ratio
 0.04 0.04 0.04 0.04 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.27 1.34 1.34 1.36 1.29
Debt Service Coverage Ratio
 1.70 1.31 2.07 3.80 1.44K
Interest Coverage Ratio
 296.33 119.98 137.48 356.42 1.13K
Debt to Market Cap
 0.07 0.06 0.05 0.06 0.00
Interest Debt Per Share
 0.42 0.45 0.47 0.40 0.01
Net Debt to EBITDA
 -9.13 -9.11 -5.78 -3.93 -4.55
Profitability Margins
Gross Profit Margin
71.27%72.28%74.95%75.15%74.38%
EBIT Margin
24.41%21.75%22.13%27.52%23.23%
EBITDA Margin
29.90%24.01%26.52%31.44%27.93%
Operating Profit Margin
24.41%21.75%22.30%21.60%18.06%
Pretax Profit Margin
39.85%40.48%30.33%27.46%23.21%
Net Profit Margin
30.14%30.30%22.24%21.47%18.30%
Continuous Operations Profit Margin
30.14%30.30%22.24%21.47%18.30%
Net Income Per EBT
75.63%74.84%73.32%78.17%78.82%
EBT Per EBIT
163.28%186.09%135.97%127.14%128.51%
Return on Assets (ROA)
7.63%8.81%8.37%10.13%8.78%
Return on Equity (ROE)
9.81%11.78%11.25%13.78%11.32%
Return on Capital Employed (ROCE)
7.72%8.25%11.10%13.66%10.87%
Return on Invested Capital (ROIC)
5.63%5.93%7.79%10.25%8.58%
Return on Tangible Assets
7.77%8.96%8.53%10.34%9.01%
Earnings Yield
16.76%16.28%12.25%19.12%14.28%
Efficiency Ratios
Receivables Turnover
 3.13 3.06 3.14 3.58 4.05
Payables Turnover
 3.08 2.56 2.35 2.32 3.28
Inventory Turnover
 1.35 1.26 1.16 1.25 1.54
Fixed Asset Turnover
 2.14 2.51 3.10 3.75 3.25
Asset Turnover
 0.25 0.29 0.38 0.47 0.48
Working Capital Turnover Ratio
 0.39 0.48 0.64 0.83 0.81
Cash Conversion Cycle
 268.01 266.73 274.34 236.13 215.89
Days of Sales Outstanding
 116.63 119.17 116.11 101.86 90.09
Days of Inventory Outstanding
 269.86 290.41 313.66 291.93 237.12
Days of Payables Outstanding
 118.49 142.84 155.43 157.65 111.32
Operating Cycle
 386.50 409.58 429.77 393.78 327.21
Cash Flow Ratios
Operating Cash Flow Per Share
 1.41 1.55 1.27 1.23 1.47
Free Cash Flow Per Share
 1.18 1.29 1.09 1.04 1.30
CapEx Per Share
 0.23 0.26 0.19 0.19 0.17
Free Cash Flow to Operating Cash Flow
 0.84 0.83 0.85 0.85 0.88
Dividend Paid and CapEx Coverage Ratio
 1.82 2.12 1.76 2.02 2.99
Capital Expenditure Coverage Ratio
 6.09 5.92 6.87 6.46 8.57
Operating Cash Flow Coverage Ratio
 3.42 3.50 2.78 3.10 149.11
Operating Cash Flow to Sales Ratio
 0.40 0.37 0.25 0.21 0.28
Free Cash Flow Yield
18.73%16.69%12.00%15.54%19.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.00 6.13 8.17 5.23 7.00
Price-to-Sales (P/S) Ratio
 1.80 1.86 1.82 1.12 1.28
Price-to-Book (P/B) Ratio
 0.58 0.72 0.92 0.72 0.79
Price-to-Free Cash Flow (P/FCF) Ratio
 5.34 5.99 8.33 6.43 5.16
Price-to-Operating Cash Flow Ratio
 4.46 4.98 7.12 5.44 4.56
Price-to-Earnings Growth (PEG) Ratio
 -1.63 0.45 -0.61 0.16 0.24
Enterprise Value Multiple
 -3.12 -1.36 1.06 -0.36 0.04
Enterprise Value
 -2.46B -1.02B 1.07B -515.64M 43.85M
EV to EBITDA
 -3.11 -1.36 1.06 -0.36 0.04
EV to Sales
 -0.93 -0.33 0.28 -0.11 0.01
EV to Free Cash Flow
 -2.77 -1.05 1.29 -0.65 0.04
EV to Operating Cash Flow
 -2.31 -0.87 1.11 -0.55 0.04
Tangible Book Value Per Share
 10.63 10.44 9.62 9.03 8.17
Shareholders’ Equity Per Share
 10.86 10.68 9.87 9.29 8.45
Tax and Other Ratios
Effective Tax Rate
 0.24 0.25 0.27 0.22 0.21
Revenue Per Share
 3.50 4.15 4.99 5.96 5.23
Net Income Per Share
 1.06 1.26 1.11 1.28 0.96
Tax Burden
 0.76 0.75 0.73 0.78 0.79
Interest Burden
 1.63 1.86 1.37 1.00 1.00
Research & Development to Revenue
 0.04 0.03 0.03 0.02 0.03
SG&A to Revenue
 0.41 0.46 0.50 0.07 0.07
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.33 0.92 0.84 0.75 1.54
Currency in CNY